A novel link between Campylobacter jejuni bacteriophage defence, virulence and Guillain-Barré syndrome.
about
Alternative roles for CRISPR/Cas systems in bacterial pathogenesisHigh-resolution transcriptome maps reveal strain-specific regulatory features of multiple Campylobacter jejuni isolatesDiversity of CRISPR-Cas immune systems and molecular machinesClassification and evolution of type II CRISPR-Cas systemsCRISPR-Cas: biology, mechanisms and relevanceSurvival and Evolution of CRISPR-Cas System in Prokaryotes and Its ApplicationsFrequently asked questions on seven rare adverse events following immunization.A CRISPR-Cas system enhances envelope integrity mediating antibiotic resistance and inflammasome evasion.CRISPR-Cas systems: beyond adaptive immunity.NilD CRISPR RNA contributes to Xenorhabdus nematophila colonization of symbiotic host nematodes.A CRISPR/Cas system mediates bacterial innate immune evasion and virulenceImpact of a single phage and a phage cocktail application in broilers on reduction of Campylobacter jejuni and development of resistanceCRISPR-Cas immunity against phages: its effects on the evolution and survival of bacterial pathogens.I can see CRISPR now, even when phage are gone: a view on alternative CRISPR-Cas functions from the prokaryotic envelope.Clustered Regularly Interspaced Short Palindromic Repeat-Dependent, Biofilm-Specific Death of Pseudomonas aeruginosa Mediated by Increased Expression of Phage-Related Genes.Analysis of the type II-A CRISPR-Cas system of Streptococcus agalactiae reveals distinctive features according to genetic lineages.Differential Distribution of Type II CRISPR-Cas Systems in Agricultural and Nonagricultural Campylobacter coli and Campylobacter jejuni Isolates Correlates with Lack of Shared EnvironmentsThe CRISPR-associated gene cas2 of Legionella pneumophila is required for intracellular infection of amoebae.Polymorphism of CRISPR shows separated natural groupings of Shigella subtypes and evidence of horizontal transfer of CRISPR.Virulence and Genomic Feature of Multidrug Resistant Campylobacter jejuni Isolated from Broiler Chicken.Degeneration of a CRISPR/Cas system and its regulatory target during the evolution of a pathogen.The role of CRISPR-Cas systems in virulence of pathogenic bacteriaPhage-Enabled Nanomedicine: From Probes to Therapeutics in Precision MedicineCRISPR-Cas systems: new players in gene regulation and bacterial physiology.Impact of CRISPR immunity on the emergence and virulence of bacterial pathogens.Suppressing the CRISPR/Cas adaptive immune system in bacterial infections.The CRISPR-Cas9 system in Neisseria spp.A decade of discovery: CRISPR functions and applications.CRISPR-Cas systems exploit viral DNA injection to establish and maintain adaptive immunity.Regulated CRISPR Modules Exploit a Dual Defense Strategy of Restriction and Abortive Infection in a Model of Prokaryote-Phage CoevolutionOverview of CRISPR-Cas9 Biology.Campylobacter jejuni acquire new host-derived CRISPR spacers when in association with bacteriophages harboring a CRISPR-like Cas4 proteinNuclease activity of Legionella pneumophila Cas2 promotes intracellular infection of amoebal host cells.Evolution and comparative genomics of Campylobacter jejuni ST-677 clonal complex.Association of clustered regularly interspaced short palindromic repeat (CRISPR) elements with specific serotypes and virulence potential of shiga toxin-producing Escherichia coliType I CRISPR-Cas targets endogenous genes and regulates virulence to evade mammalian host immunity.RNA-Independent DNA Cleavage Activities of Cas9 and Cas12a.Type II-C CRISPR-Cas9 Biology, Mechanism, and Application.Cas9 enhances bacterial virulence by repressing the regR transcriptional regulator in Streptococcus agalactiae.A combination of MLST and CRISPR typing reveals dominant Campylobacter jejuni types in organically farmed laying hens.
P2860
Q21089594-76B15A14-2979-446B-B96F-F9A643FFE6E9Q24489927-18687BD4-7306-4092-A9CE-0E6842CAA5C5Q26778564-651F3D9D-C753-43DC-8C13-5D010B343597Q26850610-13B40366-A06D-469C-B722-FF021634175AQ28069426-08826460-EFDC-46D3-AABE-657D3F2DE73CQ28079111-E68355D7-54E0-486C-A15F-BB626113B51BQ30234430-AEB66408-5484-40EA-812D-80C91D27D26CQ34002469-4C4007B5-D4F2-4433-BF37-26DC63FB0E3DQ34040445-BB18E9C9-8AB8-4B3A-8CA7-046DF2C62728Q34124570-D51AC699-27D4-493C-A380-ADCA146BA0EDQ34339102-A87E4500-CBE2-4D59-85FF-D53D869790A5Q35036500-D5D2468C-B14F-4E4A-8DB1-2C25B7BE0C11Q35069169-198DEF4D-BD72-4D88-9BB4-D64FD7A12B4BQ35554781-16671901-DB19-4824-8104-607017F28520Q35620133-BA421291-C3E4-4F8A-A3D0-A9FBFF0C963EQ35739591-4C11798F-96B2-47E1-983B-9C0C54FACA71Q36166697-C850CADE-0808-4041-9AB9-0F40B53E506FQ36706289-09AC6A10-B507-4E8B-A586-0135B4F2F0FEQ36791488-5465A177-1879-4E74-A6CB-01D6BDEBF7F2Q37339340-0BEB3776-9784-4536-9D07-10BD1EF61656Q37399515-40207D57-C8BC-44B7-AA5E-CBD0904C7FABQ37643438-35A405FB-BD62-4B09-8623-F954D8D75BD0Q37644025-736C8A47-D68F-4FB3-8049-B9807ED811C4Q37697673-45F7401C-7CE2-4C3A-A102-A36A26994CA6Q38192180-5003DE80-98F7-4A31-8C1B-23684E04B1BBQ39022294-BD3B1D25-34B1-4E30-B67A-6EFC28744F35Q39215410-4146C1B7-C0B2-40AD-9343-040CAAF8D30FQ39350951-8ED5C0FA-75E7-4196-A6A4-A0336A8F738BQ40268797-5B9BA86E-5665-40E2-8386-1F25DE723F98Q40348396-131D92D2-822F-401D-B835-6FB9D7E6F54CQ40416750-7D910FED-2916-4578-BE7F-91FCA2C6C484Q41533646-8E4D610A-72AC-4F70-A355-35F5AFF5B439Q41577231-2E850A24-49F6-4FB7-80BA-94B495D74FCFQ41751968-ACFA7843-F9CD-4D12-81FF-F86DF79081A0Q41907978-E50D58BA-CE14-4F11-8F5E-1350067179F8Q44773384-0A26DC93-611F-4BF0-87A3-F44AF3A1C290Q47251541-55C3AD8C-DC13-479B-87B3-D2CBF4B4FB8AQ47334186-0E2B7BF1-5649-4AB2-9920-F0880A8132BEQ47921177-2E0ECFA9-9D4D-4F6A-AC0A-87733D7AE84BQ52422974-71120714-DCC6-4C88-91C5-FF4F7CD4C6F4
P2860
A novel link between Campylobacter jejuni bacteriophage defence, virulence and Guillain-Barré syndrome.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
A novel link between Campyloba ...... e and Guillain-Barré syndrome.
@en
A novel link between Campyloba ...... e and Guillain-Barré syndrome.
@nl
type
label
A novel link between Campyloba ...... e and Guillain-Barré syndrome.
@en
A novel link between Campyloba ...... e and Guillain-Barré syndrome.
@nl
prefLabel
A novel link between Campyloba ...... e and Guillain-Barré syndrome.
@en
A novel link between Campyloba ...... e and Guillain-Barré syndrome.
@nl
P2093
P2860
P50
P921
P1476
A novel link between Campyloba ...... ce and Guillain-Barré syndrome
@en
P2093
A G de Boer
A P Heikema
A van Belkum
B C Jacobs
D Horst-Kreft
E E S Nieuwenhuis
G de Knegt
J A Wagenaar
P2860
P2888
P304
P356
10.1007/S10096-012-1733-4
P577
2012-09-04T00:00:00Z